Over 400 experts from 28 provinces attended the 12th National Academic Conference on Minimally Invasive Surgery in Aerospace. We are proud that, for the third consecutive year, our Chinese partner, Chenglai Pharmaceutical, was among the key players at this prestigious...
Elesta announces that the Chinese regulatory authority National Medical Products Administration (NMPA) has approved EchoLaser for use in prostatic diseases. This approval is a major achievement and represents a great opportunity for Elesta (distributed in China by...
The theoretical – practical course at the LXY Institute in Madrid, where EchoLaser TPLA played a central role as a treatment for IPB, ended. Discover more thanks to Dr. Pablo Garrido Abad! III Edición Curso Práctico en STUI y Patología Vesicoprostática basado en...
At Elesta, we are committed to improving men’s health and that’s why we are proud to be part of the Movember movement this November. Together with EchoLaser TPLATM, we’re taking a stand for a cause that matters. 🌟 *Our Mission:* Elesta is dedicated...
We are happy to say that #EchoLaser #SoracteLite #TPLA has been recognized as one of the most crucial updates for #EAU23. A safe way to treat #BPH that preserves sexual function....
This site uses cookies to provide you with a better browsing experience. By accepting this banner, scrolling down this page, clicking on a link or continuing to browse in any other way, you consent to the use of cookies. If want to know more read our cookie policy.
